MedTrace Logo

Screening for Colorectal Cancer With FOBT, Virtual Colonoscopy and Optical Colonoscopy. A Randomized Clinical Trial in the Florence District

NCT01651624 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16087

Last updated 2018-11-27

No results posted yet for this study

Summary

RATIONALE: Computed tomographic colonography (CTC) has proven to be accurate in detecting colorectal neoplasms and may be a primary test in colorectal cancer screening.

PURPOSE: This clinical trial will compare participation rate, diagnostic yield and costs of computed tomographic colonography, faecal occult blood test (FOBT) and colonoscopy (CO) as a primary screening test in a population-based programme.

Conditions

Interventions

OTHER

Invitation to screening

Sponsors & Collaborators

  • University of Florence

    collaborator OTHER

  • Cancer Prevention and Research Institute, Italy

    lead OTHER

Principal Investigators

  • Stefano Milani, MD · University of Florence

  • Grazia Grazzini, MD · Cancer Prevention and Research Institute, Italy

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2018-11-25
Completion
2018-11-25

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01651624 on ClinicalTrials.gov